Call Options Transactions Made in Q2 2023 in Biocryst Pharmaceuticals Inc (BCRX)
This table provides information about the institutional ownership of Biocryst Pharmaceuticals Inc (BCRX) during Q2 2023. The information is specifically focused on institutions that hold call options of BIOCRYST PHARMACEUTICALS INC.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 10, 2023
Q2 2023
|
Citigroup Inc
|
BUY
|
CALL |
39.9KNew |
$278K - $352K
|
39.9K
$299K
|
|
|
Aug 14, 2023
Q2 2023
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
BUY
|
CALL |
14K+ 2.38% |
$97.4K - $123K
|
603K
$4.52M
|
|
|
Aug 14, 2023
Q2 2023
|
Walleye Capital LLC
Plymouth, MN |
BUY
|
CALL |
3K+ 23.81% |
$20.9K - $26.4K
|
15.6K
$117K
|
|
|
Aug 14, 2023
Q2 2023
|
Walleye Trading LLC
Plymouth, MN |
SELL
|
CALL |
-4.3K- 25.9% |
$29.9K - $37.9K
|
12.3K
$92.1K
|
|
|
Aug 23, 2023
Q2 2023
|
Wolverine Trading, LLC
Chicago, IL |
SELL
|
CALL |
-12.7K- 12.37% |
$88.4K - $112K
|
90K
$674K
|
|
|
Aug 14, 2023
Q2 2023
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
CALL |
-138K- 57.84% |
$963K - $1.22M
|
101K
$756K
|
|
|
Aug 11, 2023
Q2 2023
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
SELL
|
CALL |
-297K- 32.75% |
$2.07M - $2.62M
|
610K
$4.57M
|